ADH1B and type 2 diabetes mellitus: A transcriptomic study of obese vs non-obese subjects approximately equally divided into 3 T2D-related categories (T2D, IGT and NGT; total N = 33) found a significant decrease in ADH1B expression in each of the 3 obese groups compared with the matched controls (GEO accession GSE27951)[40].